NOTV — Inotiv, Inc.
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 720154 ·
Last close
$0.27
Market Cap
$9.30M
52W High
$0.48
52W Low
$0.22
ADV30
1,083,073
Next earnings
2026-08-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 117,652,000 | 24,649,000 | -17,125,000 | -32,467,000 | 702,418,000 | 15,180,000 | 625,319,000 |
| Dec 2025 | 120,879,000 | 24,810,000 | -16,144,000 | -28,378,000 | 734,336,000 | 12,732,000 | 625,312,000 |
| Sep 2025 | 138,142,000 | 33,029,000 | -6,706,000 | -8,552,000 | 771,114,000 | 21,741,000 | 635,086,000 |
| Jun 2025 | 130,683,000 | 33,922,000 | -5,530,000 | -17,577,000 | 759,737,000 | 6,215,000 | 615,952,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-11,391,000
Investing CF
$-13,612,000
Financing CF
$-888,000
CapEx
$-17,336,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.03
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-659,191,000
Inventory
$44,320,000
Receivables
$88,540,000
ST Investments
—
EBIT TTM
$-31,758,000
Pretax Income TTM
$-87,976,000
Interest Exp TTM
$56,218,000
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$507,356,000
EBITDA
$8,559,000
Free Cash Flow
$23,620,376
Enterprise Value
$482,005,792
Total Cash
$15,180,000
Total Debt
$487,766,016
Shares Out
34,888,147
Trailing EPS
$-2.49
Book Value
$2.21
ROE
-74.1%
ROA
-4.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 513,024,000 | -36,998,000 | -68,625,000 | 771,114,000 | 635,086,000 | — | -10,455,000 |
| Sep 2024 | 490,739,000 | -54,462,000 | -108,445,000 | 781,361,000 | 610,857,000 | — | -6,805,000 |
| Sep 2023 | 572,425,000 | -9,240,000 | -105,140,000 | 856,530,000 | 588,040,000 | — | 27,883,000 |
| Sep 2022 | 547,656,000 | 20,251,000 | -337,018,000 | 962,900,000 | 603,134,000 | — | -5,217,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.05
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BMRA | BIOMERICA INC | $7.63M | $2.47 | — |
| BIAF | bioAffinity Technologies, Inc. | $7.48M | $1.65 | — |
| NYMXF | NYMOX PHARMACEUTICAL CORP | $12.29M | $0.13 | — |
| TRIB | TRINITY BIOTECH PLC | $13.10M | $0.65 | — |
| CDIO | Cardio Diagnostics Holdings, Inc. | $5.24M | $1.77 | — |
News headlines (Yahoo Finance, 1h cache)
How The Inotiv (NOTV) Investment Story Is Shifting As Expectations And Risks Are Recast
2026-04-15 23:07 · Yahoo
How Inotiv (NOTV) Narrative Is Shifting As Analysts Reset Fair Value Expectations
2026-03-04 07:07 · Yahoo
Inotiv Inc (NOTV) Q1 2026 Earnings Call Highlights: Navigating Growth Amidst Challenges
2026-02-17 01:01 · Yahoo
Inotiv Provides Notice Regarding Cybersecurity Incident
2026-02-13 21:30 · Yahoo
Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update
2026-02-09 12:00 · Yahoo
Inotiv, Inc. to Report Fiscal 2026 First Quarter Financial Results and Host Conference Call on Monday, February 9, 2026
2026-02-04 11:30 · Yahoo
Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery
2026-01-13 14:15 · Yahoo
Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities
2025-12-11 14:00 · Yahoo
Inotiv Inc (NOTV) Q4 2025 Earnings Call Highlights: Revenue Growth Amid Cybersecurity Challenges
2025-12-04 23:05 · Yahoo
Inotiv, Inc. Q4 2025 Earnings Call Summary
2025-12-04 13:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.